FDA Approves a New PARP Inhibitor for BRCA-mutant Breast Cancer
In the midst of Breast Cancer Awareness Month, the US. Food and Drug Administration (FDA) provided good news for...
Category: Meetings
In the midst of Breast Cancer Awareness Month, the US. Food and Drug Administration (FDA) provided good news for...
The 30th Anniversary AACR Special Conference Convergence: Artificial Intelligence, Big Data, and Prediction in Cancer is focusing on a...
As a monthly feature on this blog, we spotlight the 10 articles selected by our editors from each journal...
While immunotherapy may be the latest tool in the treatment armamentarium for cancer, many ongoing clinical trials are assessing...
The AACR Annual Meeting 2018 drew more than 22,600 people to Chicago, providing a front-row seat to some exciting...
A study presented at the AACR Annual Meeting 2018 discussed preliminary data on an off-the-shelf, T-cell receptor (TCR)-less, dual-targeted...
An exciting area in drug development, immunotherapy is being increasingly utilized by patients with different cancer types. These treatments...
This post originally appeared on the Cancer Today website. “This is a historic time in cancer research,” said Elizabeth...
As the 2018 Annual Meeting of the American Association for Cancer Research unfolded yesterday morning, the excitement among the...
The AACR’s Pediatric Cancer Working Group, which now boasts over 2,500 members, will hold a special scientific session at...